H.B. Fuller (FUL) Aandelenoverzicht
H.B. Fuller Company, samen met haar dochterondernemingen, formuleert, produceert en verkoopt kleefstoffen, dichtingsmiddelen, coatings, polymeren, tapes, inkapselmiddelen, additieven en andere speciale chemische producten. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 4/6 |
| Financiële gezondheid | 3/6 |
| Dividenden | 5/6 |
FUL Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
H.B. Fuller Company Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$61.95 |
| 52 Week Hoogtepunt | US$68.63 |
| 52 Week Laag | US$48.71 |
| Bèta | 0.96 |
| 1 maand verandering | 2.30% |
| 3 maanden verandering | 4.70% |
| 1 Jaar Verandering | -0.064% |
| 3 jaar verandering | -10.53% |
| 5 jaar verandering | -4.07% |
| Verandering sinds IPO | 2,452.45% |
Recent nieuws en updates
Analyseartikel • Jun 18
H.B. Fuller (FUL) Stock Could Be 8% Undervalued After Its 2025 Sustainability Report
H.B. Fuller (FUL) is in focus after publishing its 2025 Sustainability Report, which sets out 2030 goals on greenhouse gas emissions, water use, and waste intensity, and links these efforts to operations and customer demand. See our latest analysis for H.B. Fuller. Recent trading suggests momentum in H.B. Fuller stock has been picking up, with a 30 day share price return of 11.27% and a 90 day share price return of 28.74%. The 1 year total shareholder return of 21.62% gives investors context...Seeking Alpha • Jun 16
H.B. Fuller: Margin Growth Looks Unsustainable
Summary H.B. Fuller is rated a sell due to persistent revenue declines, cost inflation, and acquisition risks despite margin improvements. FUL's topline continues to shrink as price hikes fail to offset volume declines; margin gains are driven by transient cost synergies and divestitures. The proposed $800M AMS acquisition risks over-leveraging FUL’s balance sheet, drawing activist pushback and raising medium-term risk. FUL trades at a sales multiple of 1, below the sector median, reflecting weak growth and uncertain outlook if topline recovery fails. Read the full article on Seeking Alpha
Narratiefupdate • Jun 16
FUL: Medical Deal Uncertainty And Activist Pressure Will Shape Future Outlook
Analysts have made a small, valuation-driven adjustment to their view on H.B. Fuller, with the blended price target holding close to prior levels as updated models reflect a slightly lower discount rate, largely stable fair value at about $70, and balanced input from recent upgrades and price target revisions across the Street. Analyst Commentary Recent commentary on H.B. Fuller centers on how potential corporate actions and updated models could influence the stock’s risk and reward profile, with JPMorgan’s upgrade and various price target changes framing a mixed but valuation conscious view.Recent updates
Analyseartikel • Jun 18
H.B. Fuller (FUL) Stock Could Be 8% Undervalued After Its 2025 Sustainability Report
H.B. Fuller (FUL) is in focus after publishing its 2025 Sustainability Report, which sets out 2030 goals on greenhouse gas emissions, water use, and waste intensity, and links these efforts to operations and customer demand. See our latest analysis for H.B. Fuller. Recent trading suggests momentum in H.B. Fuller stock has been picking up, with a 30 day share price return of 11.27% and a 90 day share price return of 28.74%. The 1 year total shareholder return of 21.62% gives investors context...Seeking Alpha • Jun 16
H.B. Fuller: Margin Growth Looks Unsustainable
Summary H.B. Fuller is rated a sell due to persistent revenue declines, cost inflation, and acquisition risks despite margin improvements. FUL's topline continues to shrink as price hikes fail to offset volume declines; margin gains are driven by transient cost synergies and divestitures. The proposed $800M AMS acquisition risks over-leveraging FUL’s balance sheet, drawing activist pushback and raising medium-term risk. FUL trades at a sales multiple of 1, below the sector median, reflecting weak growth and uncertain outlook if topline recovery fails. Read the full article on Seeking AlphaNarratiefupdate • Jun 16
FUL: Medical Deal Uncertainty And Activist Pressure Will Shape Future Outlook
Analysts have made a small, valuation-driven adjustment to their view on H.B. Fuller, with the blended price target holding close to prior levels as updated models reflect a slightly lower discount rate, largely stable fair value at about $70, and balanced input from recent upgrades and price target revisions across the Street. Analyst Commentary Recent commentary on H.B. Fuller centers on how potential corporate actions and updated models could influence the stock’s risk and reward profile, with JPMorgan’s upgrade and various price target changes framing a mixed but valuation conscious view.Narratiefupdate • Jun 02
FUL: Proposed Medical Solutions Deal Will Shape Long Term Outlook
Analysts kept their fair value estimate for H.B. Fuller steady at $70.43 while adjusting assumptions such as the discount rate and long-term growth. This reflected mixed recent price target moves as firms reassessed the stock around potential corporate actions and valuation.Narratiefupdate • Apr 26
FUL: Raised Guidance And P/E Assumptions Will Support Stronger Long Term Outlook
Analysts have adjusted their outlook on H.B. Fuller, with offsetting moves such as a $3 increase in the price target at Citi and a $3 reduction at UBS. These changes are framed around updated views on valuation inputs such as the discount rate and the assumed future P/E multiple.Narratiefupdate • Apr 12
FUL: Long Term Assumptions Will Support Balanced Outlook Despite Mixed Guidance
The analyst price target for H.B. Fuller edges slightly lower to about $70.43 from roughly $70.71, as analysts balance recent target increases from several firms with more cautious revisions tied to adjusted growth, margin, and P/E assumptions. Analyst Commentary Recent Street research on H.B. Fuller presents a mixed picture, with several firms adjusting price targets both higher and lower over the past few months.Narratiefupdate • Mar 29
FUL: Higher Long Term Assumptions Will Support Upside Despite Mixed Guidance
Analysts trimmed the average H.B. Fuller price target by about $1 to $70.71, reflecting a mix of recent upward and downward revisions as they reassessed assumptions on growth, profitability, and valuation multiples. Analyst Commentary Recent research on H.B. Fuller features a mix of higher and lower price targets.Narratiefupdate • Mar 14
FUL: Higher P/E Assumptions Will Support Upside Despite Muted Revenue Outlook
Analysts have lifted their consolidated price target on H.B. Fuller by several dollars, with recent $2 to $6 upward revisions tied to their updated views on the company’s earnings power and P/E assumptions. Analyst Commentary Bullish analysts raising their targets by $2 to $6 are largely reacting to updated assumptions on H.B. Fuller’s earnings power and the P/E they are willing to apply to those earnings.Narratiefupdate • Feb 28
FUL: Free Cash Flow Support Will Offset Modest Outlook And Future P/E Assumptions
H.B. Fuller’s analyst price target has been lifted by several firms, with recent increases of $2 to $6 reflecting analysts’ updated views on its earnings profile and modest adjustments to assumptions such as discount rate, long-term revenue growth, profit margin, and future P/E. Analyst Commentary Recent Street research points to a cluster of higher price targets for H.B. Fuller, with adjustments in the range of $2 to $6.Narratiefupdate • Feb 14
FUL: Free Cash Flow Support Will Balance Organic Headwinds And Future P/E Expectations
The Street has nudged its view on H.B. Fuller higher, with analysts lifting price targets by $2 to $6 as they point to a mix of free cash flow support and valuation considerations, even as they flag near term organic growth headwinds. Analyst Commentary Recent Street research clusters around a common theme for H.B. Fuller, with price target increases framed against ongoing pressure on near term organic growth.Narratiefupdate • Jan 31
FUL: Free Cash Flow Support Will Underpin Higher Future P/E Expectations
Analysts have lifted their price targets on H.B. Fuller by between $2 and $6, citing updated views on valuation, free cash flow support, and a slightly higher assumed future P/E multiple in their models. Analyst Commentary Recent research updates show a cluster of higher price targets for H.B. Fuller, with several firms revisiting their models to reflect revised valuation assumptions, free cash flow support, and modestly higher assumed future P/E multiples.Narratiefupdate • Jan 17
FUL: Higher P/E Expectations Will Shape Medium Term Earnings Power
Analysts have raised their price targets for H.B. Fuller, reflected in the fair value estimate increasing from $68.83 to $71.71. This change is based on a higher assumed future P/E multiple, along with slightly revised assumptions for the discount rate, revenue growth, and profit margins.Analyseartikel • Jan 08
Investors Will Want H.B. Fuller's (NYSE:FUL) Growth In ROCE To Persist
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Analyseartikel • Nov 14
We Think H.B. Fuller (NYSE:FUL) Is Taking Some Risk With Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyseartikel • Oct 03
There May Be Reason For Hope In H.B. Fuller's (NYSE:FUL) Disappointing Earnings
Soft earnings didn't appear to concern H.B. Fuller Company's ( NYSE:FUL ) shareholders over the last week. Our analysis...Analyseartikel • Sep 30
H.B. Fuller Company Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Shareholders might have noticed that H.B. Fuller Company ( NYSE:FUL ) filed its quarterly result this time last week...Narratiefupdate • Sep 28
ND Industries Integration And HHC Pricing Will Secure Stability
Analysts have raised H.B. Fuller's price target to $68.83, citing confidence in continued EBITDA growth, margin expansion, and operational execution despite a weak growth environment. Analyst Commentary Bullish analysts highlight solid year-over-year EBITDA growth expected in fiscal 2025, despite a sluggish growth environment.Analyseartikel • Aug 30
Estimating The Intrinsic Value Of H.B. Fuller Company (NYSE:FUL)
Key Insights Using the 2 Stage Free Cash Flow to Equity, H.B. Fuller fair value estimate is US$53.78 With US$61.05...Analyseartikel • Aug 14
H.B. Fuller Company's (NYSE:FUL) P/E Is On The Mark
H.B. Fuller Company's ( NYSE:FUL ) price-to-earnings (or "P/E") ratio of 31.7x might make it look like a strong sell...Analyseartikel • Jul 30
Is Now The Time To Look At Buying H.B. Fuller Company (NYSE:FUL)?
While H.B. Fuller Company ( NYSE:FUL ) might not have the largest market cap around , it saw a double-digit share price...Analyseartikel • Jul 15
There's Been No Shortage Of Growth Recently For H.B. Fuller's (NYSE:FUL) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...Analyseartikel • May 22
Is H.B. Fuller Company (NYSE:FUL) Worth US$54.7 Based On Its Intrinsic Value?
Key Insights Using the 2 Stage Free Cash Flow to Equity, H.B. Fuller fair value estimate is US$41.64 H.B. Fuller is...Analyseartikel • May 07
H.B. Fuller (NYSE:FUL) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analyseartikel • Apr 19
H.B. Fuller (NYSE:FUL) Will Pay A Larger Dividend Than Last Year At $0.235
The board of H.B. Fuller Company ( NYSE:FUL ) has announced that it will be increasing its dividend by 5.6% on the 13th...Analyseartikel • Apr 10
Here's What To Make Of H.B. Fuller's (NYSE:FUL) Decelerating Rates Of Return
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Analyseartikel • Mar 13
Shareholders Should Be Pleased With H.B. Fuller Company's (NYSE:FUL) Price
With a price-to-earnings (or "P/E") ratio of 22.4x H.B. Fuller Company ( NYSE:FUL ) may be sending bearish signals at...Analyseartikel • Feb 21
What Is H.B. Fuller Company's (NYSE:FUL) Share Price Doing?
H.B. Fuller Company ( NYSE:FUL ), is not the largest company out there, but it saw significant share price movement...Analyseartikel • Jan 23
We Think You Can Look Beyond H.B. Fuller's (NYSE:FUL) Lackluster Earnings
Shareholders appeared unconcerned with H.B. Fuller Company's ( NYSE:FUL ) lackluster earnings report last week. We...Seeking Alpha • Jan 17
Evaluation Of H.B. Fuller After A 30% Decline
Summary H.B. Fuller missed analysts' estimates for the second consecutive quarter, leading to a 3% stock decline and hitting a nearly 3-year low. Despite recent stagnation, H.B. Fuller expects to realize price hikes in 2025, with projected earnings per share growth of 5% and potential for significant future gains. The stock's sharp 30% decline is attributed to its initially high valuation; it now trades at a more reasonable 15.0x forward P/E ratio. Given its cyclical nature, H.B. Fuller offers substantial upside potential but is not a long-term hold; investors should reassess at $79 target. Read the full article on Seeking AlphaAnalyseartikel • Dec 21
Does H.B. Fuller (NYSE:FUL) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Seeking Alpha • Dec 08
H.B. Fuller: Still Not Fully Onboard
Summary H.B. Fuller faces lackluster revenue growth and margin pressure despite M&A activities, leading to cautious investment sentiment and a neutral stance. The company has a long heritage, generating $3.5 billion in 2023 sales, but inventory de-stocking and soft trends have weighed on sales growth for a while. Recent acquisitions and reorganization efforts have increased net debt to $2 billion, raising leverage ratios to 3.2-3.3 times amidst flat organic sales. I remain cautious and seek an entry point in the mid-sixties, given the current 18 times earnings multiple and expensive portfolio reshuffling. Read the full article on Seeking AlphaRendement voor aandeelhouders
| FUL | US Chemicals | US Markt | |
|---|---|---|---|
| 7D | -4.5% | 0.7% | -2.7% |
| 1Y | -0.06% | 7.4% | 18.6% |
Rendement versus industrie: FUL presteerde slechter dan de US Chemicals -sector, die het afgelopen jaar een rendement van 7.4 % opleverde.
Rendement versus markt: FUL presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 18.6 % opleverde.
Prijsvolatiliteit
| FUL volatility | |
|---|---|
| FUL Average Weekly Movement | 5.5% |
| Chemicals Industry Average Movement | 6.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: FUL heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van FUL is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1887 | 7,100 | Celeste Mastin | www.hbfuller.com |
H.B. Fuller Company, samen met haar dochterondernemingen, formuleert, produceert en verkoopt kleefstoffen, dichtingsmiddelen, coatings, polymeren, tapes, inkapselmiddelen, additieven en andere speciale chemische producten. Het bedrijf is actief in drie segmenten: Hygiëne-, gezondheids- en verbruikslijmen; technische kleefstoffen; en bouwkleefoplossingen. Het segment Hygiëne, Gezondheid en Verbruiksartikelen produceert en levert speciale industriële kleefstoffen, zoals thermoplastische, thermohardende, reactieve, op water gebaseerde en op oplosmiddelen gebaseerde producten voor toepassingen in verschillende markten, waaronder verpakking, verwerking, non-woven en hygiëne, en medische en schoonheidsverzorging.
H.B. Fuller Company Samenvatting
| FUL fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$3.47b |
| Inkomsten(TTM) | US$185.74m |
| Inkomsten(TTM) | US$3.51b |
17.9x
Koers/Winstverhouding0.9x
P/S-verhoudingIs FUL overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| FUL resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$3.51b |
| Kosten van inkomsten | US$2.38b |
| Brutowinst | US$1.13b |
| Overige uitgaven | US$945.59m |
| Inkomsten | US$185.74m |
Laatst gerapporteerde inkomsten
May 30, 2026
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 3.45 |
| Brutomarge | 32.25% |
| Nettowinstmarge | 5.29% |
| Schuld/Eigen Vermogen Verhouding | 99.5% |
Hoe presteerde FUL op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
1.5%
Huidig dividendrendement28%
UitbetalingsratioBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/06/25 08:30 |
| Aandelenkoers aan het einde van de dag | 2026/06/25 00:00 |
| Inkomsten | 2026/05/30 |
| Jaarlijkse inkomsten | 2025/11/29 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
H.B. Fuller Company wordt gevolgd door 12 analisten. 7 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Ghansham Panjabi | Baird |
| Paretosh Misra | Berenberg |
| Patrick Cunningham | Citigroup Inc |